Trial Profile
Pharmacokinetics and measurement of drug levels of Enteric Coated Mycophenolic sodium in Lupus Nephritis Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jun 2016
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- Acronyms POEMSLUN
- Sponsors Novartis
- 08 Jun 2016 Status changed from recruiting to completed.
- 23 May 2013 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry.
- 16 Aug 2011 New trial record